RESULTS OF OPERATIONS
We manufacture, market and sell beauty products including those in the skin
care, makeup, fragrance and hair care categories, which are distributed in
approximately 150 countries and territories. The following table is a
comparative summary of operating results for fiscal 2020, 2019 and 2018 and
reflects the basis of presentation described in Item 8. Financial Statements and
Supplementary Data - Note 2 - Summary of Significant Accounting Policies and
Note 22 - Segment Data and Related Information for all periods
presented. Products and services that do not meet our definition of skin care,
makeup, fragrance and hair care have been included in the "other" category.
                                                                          Year Ended June 30
(In millions)                                                 2020               2019               2018
NET SALES(1)
By Product Category:
Skin Care                                                 $   7,382          $   6,551          $   5,595
Makeup                                                        4,794              5,860              5,633
Fragrance                                                     1,563              1,802              1,826
Hair Care                                                       515                584                570
Other                                                            40                 69                 67
                                                             14,294             14,866             13,691
Returns associated with restructuring and other
activities                                                        -                 (3)                (8)
Net sales                                                 $  14,294          $  14,863          $  13,683

By Region:
The Americas                                              $   3,794          $   4,741          $   5,015
Europe, the Middle East & Africa                              6,262              6,452              5,634
Asia/Pacific                                                  4,238              3,673              3,042
                                                             14,294             14,866             13,691
Returns associated with restructuring and other
activities                                                        -                 (3)                (8)
Net sales                                                 $  14,294          $  14,863          $  13,683

OPERATING INCOME (LOSS)(1)
By Product Category:
Skin Care                                                 $   2,125          $   1,925          $   1,514
Makeup                                                       (1,438)               438                549
Fragrance                                                        17                140                176
Hair Care                                                       (19)                39                 64
Other                                                             4                 12                  9
                                                                689              2,554              2,312
Charges associated with restructuring and other
activities                                                      (83)              (241)              (257)
Operating income                                          $     606          $   2,313          $   2,055

By Region:
The Americas                                              $  (1,044)         $     672          $     872
Europe, the Middle East & Africa                                997              1,153                865
Asia/Pacific                                                    736                729                575
                                                                689              2,554              2,312
Charges associated with restructuring and other
activities                                                      (83)              (241)              (257)
Operating income                                          $     606          $   2,313          $   2,055

(1)The net sales and operating income from our travel retail business are included in the Europe, the Middle East & Africa region, with the exception of the net sales of Dr. Jart+ products in the travel retail channel that are reflected in Korea in the Asia/Pacific region.


                                       25
--------------------------------------------------------------------------------
  Table of Contents
During fiscal 2020, changes were made to reflect certain Leading Beauty Forward
enhancements made to the capabilities and cost structure of our travel retail
business, which are primarily centralized in The Americas region, and resulted
in a change to the royalty structure of the travel retail business to reflect
the value created in The Americas region. Accordingly, the fiscal 2019 and 2018
operating income of The Americas was increased, with a corresponding decrease in
Europe, the Middle East & Africa, by $866 million and $661 million,
respectively, to conform with the current year methodology and presentation.

The following table presents certain consolidated earnings data as a percentage of net sales:


                                                                                        Year Ended June 30
                                                                       2020                        2019                    2018
Net sales                                                                     100.0  %                100.0  %                100.0  %
Cost of sales                                                                  24.8                    22.8                    20.8
Gross profit                                                                   75.2                    77.2                    79.2

Operating expenses:
Selling, general and administrative                                            60.4                    59.6                    62.5
Restructuring and other charges                                                 0.5                     1.4                     1.7
Goodwill impairment                                                             5.7                     0.5                       -
Impairment of other intangible and long-lived assets                            4.3                     0.1                       -
Total operating expenses                                                       70.9                    61.6                    64.2

Operating income                                                                4.2                    15.6                    15.0
Interest expense                                                                1.1                     0.9                     0.9
Interest income and investment income, net                                      0.3                     0.4                     0.4
Other components of net periodic benefit cost                                     -                       -                       -
Other income, net                                                               3.9                     0.4                       -

Earnings before income taxes                                                    7.3                    15.5                    14.5
Provision for income taxes                                                     (2.4)                   (3.4)                   (6.3)

Net earnings                                                                    4.9                    12.1                     8.2
Net earnings attributable to noncontrolling interests                          (0.1)                   (0.1)                   (0.1)
Net earnings attributable to The Estée Lauder
Companies Inc.                                                                  4.8  %                 12.0  %                  8.1  %

Not adjusted for differences caused by rounding




We continually introduce new products, support new and established products
through advertising, merchandising and sampling and phase out existing products
that no longer meet the needs of our consumers or our objectives. The economics
of developing, producing, launching, supporting and discontinuing products
impact our sales and operating performance each period. The introduction of new
products may have some cannibalizing effect on sales of existing products, which
we take into account in our business planning.
Non-GAAP Financial Measures
We use certain non-GAAP financial measures, among other financial measures, to
evaluate our operating performance, which represent the manner in which we
conduct and view our business. Management believes that excluding certain items
that are not comparable from period to period helps investors and others compare
operating performance between periods. While we consider the non-GAAP measures
useful in analyzing our results, they are not intended to replace, or act as a
substitute for, any presentation included in the consolidated financial
statements prepared in conformity with U.S. GAAP. See Reconciliations of
Non-GAAP Financial Measures beginning on page 46 for reconciliations between
non-GAAP financial measures and the most directly comparable U.S. GAAP measures.

                                       26
--------------------------------------------------------------------------------
  Table of Contents
We operate on a global basis, with the majority of our net sales generated
outside the United States. Accordingly, fluctuations in foreign currency
exchange rates can affect our results of operations. Therefore, we present
certain net sales, operating results and diluted net earnings per common share
information excluding the effect of foreign currency rate fluctuations to
provide a framework for assessing the performance of our underlying business
outside the United States. Constant currency information compares results
between periods as if exchange rates had remained constant
period-over-period. We calculate constant currency information by translating
current-period results using prior-year period weighted-average foreign currency
exchange rates and adjusting for the period-over-period impact of foreign
currency cash flow hedging activities.
Overview
COVID-19 Business Update

We continue to monitor the impact of the COVID-19 pandemic, which negatively
impacted the second half of fiscal 2020, on all aspects of our business. We have
taken significant actions to help protect the health and safety of our
employees, beauty advisors and consumers, as well as to effectively manage our
business through the rapidly evolving disruptions in our operating environment.
We believe we are well-positioned to participate in the markets' recovery.
Beginning in calendar 2020, governments in various countries implemented
restrictions to prevent further spread of the virus. These include the temporary
closing of businesses deemed "non-essential," travel bans and restrictions,
social distancing and quarantines. As a result, we modified a number of our
business practices, in part due to legislation, executive orders and guidance
from government entities and healthcare authorities (collectively, "COVID-19
Directives").

Retail impact
Brick-and-mortar retail stores that sell our products across most countries have
experienced temporary or ongoing store closures and, as they re-open,
significantly reduced consumer traffic. This impacted the brick-and-mortar
retail operations of our customers, as well as our freestanding stores.
•In Asia/Pacific, nearly all retail stores have re-opened after many stores
closed for most of February 2020 through April 2020.
•In Europe, the Middle East & Africa, retail stores began closing in early March
2020 and gradually reopened through June 2020. At the end of June 2020,
approximately 15% of the stores remained closed, and by mid-August most had
re-opened.
•In The Americas, retail stores began closing in mid-March 2020. By the end of
June 2020, approximately 20% of the stores remained closed, and by mid-August,
most stores had re-opened.
•Since mid-March 2020, air travel has been largely curtailed globally, adversely
impacting the annual growth trend of our travel retail business.

Somewhat offsetting the significant declines in brick-and-mortar channels, net sales growth of our products online (through our own websites, third-party platforms and websites of our retailers) has accelerated globally.

As the pandemic continues, we are continuing to assess local conditions and when counters and our stores should re-open.



Due in large part to the challenging retail environment and, with respect to the
second half of fiscal 2020, uncertainties stemming from the COVID-19 pandemic,
we recognized Goodwill, other intangible asset and long-live asset impairments.
See Item 8. Financial Statements and Supplementary Data - Note 6 - Goodwill and
Other Intangible Assets and Note 7 - Leases for further information.

Supply Chain impact
During the second half of fiscal 2020, a majority of our facilities continued to
manufacture and distribute products globally, albeit in a much-reduced capacity
in light of safety measures designed to protect our employees in response to the
COVID-19 pandemic. By the end of our fiscal year, all manufacturing and
distribution facilities were operating with rapidly improving capacity. We have,
to date, been able to obtain raw materials and components. At this time, we
expect to be able to produce and distribute our products when the demand
increases. Our cost of sales was adversely impacted by the timing of expense
recognition and other costs, primarily caused by the COVID-19 pandemic,
including the shutdown of certain of our manufacturing facilities and the
implementation of social distancing measures. These adjustments resulted in an
increase in Cost of sales for the fiscal 2020 fourth quarter and fiscal 2020 of
$80 million and $83 million, respectively. Additionally, we recorded an increase
in excess and obsolete inventory, which resulted in an increase in Cost of sales
for the fiscal 2020 fourth quarter and fiscal 2020 of $121 million and $166
million, respectively.

                                       27
--------------------------------------------------------------------------------
  Table of Contents
Cash Conservation
As the impacts from COVID-19 evolved, we faced various uncertainties and
implemented strict cost control measures and took actions to conserve cash. Such
actions included:
•Expense reductions, including advertising and promotion activities, travel,
meetings, consulting, and certain employee costs, including implementing a
hiring freeze, furloughs and similar unpaid temporary leaves of absence for many
point of sale employees; temporary salary reductions for senior executives and
other management employees; and a temporary elimination of cash retainers for
the Board of Directors. Combined, these resulted in approximately $800 million
of savings in the last five months of fiscal 2020.
•Reduced capital investments (e.g., facilities and consumer-facing counters) by
approximately $275 million for fiscal 2020.
•Temporary suspension of discretionary repurchases of our Class A Common Stock.
•Not declaring a quarterly cash dividend that would have been paid in June 2020.
•Raising an additional $2,200 million of cash by issuing $700 million of Senior
Unsecured Notes and borrowed the full amount under our $1,500 million revolving
credit facility. In June 2020, we repaid $750 million borrowed under our
revolving credit facility, and, in August 2020, repaid the remaining $750
million.

Government Assistance
During the second half of fiscal 2020, many governments in locations where we
operate announced programs to assist employers whose businesses were impacted by
the COVID-19 pandemic, including programs that provide rebates to incentivize
employers to maintain employees on payroll who were unable to work for their
usual number of hours. During the fourth quarter of fiscal 2020, we qualified
for and recorded $99 million in government assistance, which reduced Selling,
general and administrative expenses and Cost of sales by $87 million and $10
million, respectively. The remaining $2 million was deferred and will be
recognized in fiscal 2021. We are continuing to review applicable government
assistance programs globally.
We will continue to monitor the impacts of COVID-19 and adjust our action plans
accordingly as the situation progresses.

Business Update



Our business is focused on prestige beauty, which combines the repeat purchase
and relative affordability of consumer goods with the high-quality products and
high-touch services of luxury goods. At the same time, we are well diversified
by brand, product category, geography, channel, consumer segment and price
point. Our innovation capabilities, driven by our creativity and inspired by
data analytics and consumer insights, allow us to use our brand portfolio to
capitalize on opportunities in fast growing and profitable areas of prestige
beauty. We believe that our broad and inclusive range of prestige product
offerings allows us to increase our share of a consumer's beauty routine and
compete for consumers of prestige or mass brands.

•In fiscal 2020, global prestige skin care continued to lead product category
growth. Our skin care net sales benefited from the enduring strength of hero
product lines such as Advanced Night Repair from Estée Lauder and Crème de La
Mer from La Mer, as well as recent product launches, the growth in Asia and
targeted expanded consumer reach. The launches of Advanced Night Repair Intense
Reset Concentrate and Perfectionist Rapid Brightening Treatment Serum from Estée
Lauder and The Eye Concentrate from La Mer were particularly successful in
Asia/Pacific. During fiscal 2020, our Clinique brand introduced a new serum Even
Better Clinical Dark Spot Corrector and Interrupter, which was successful in
China. Net sales of skin care products rose in international markets, led by
Estée Lauder and incremental net sales of Dr. Jart+, which we acquired in
December 2019.
•Global prestige makeup sales declined as COVID-19 limited social and business
activities and consumers wore less makeup. Some sub-categories in makeup
performed better in the COVID-19 environment, including eye products and makeup
with skin care benefits such as tinted moisturizers, while demand for lipstick
and foundation weakened. During fiscal 2020, our makeup net sales benefited from
targeted expanded consumer reach and the continued success of existing products,
such as the Double Wear franchise and Futurist line of products from Estée
Lauder, as well as The Luminous Lifting Cushion Foundation from La Mer.
•Our fragrance net sales declined as consumer demand shifted from personal
fragrance to bath, body and home. The decline was offset by strong growth and
targeted expanded consumer reach of Le Labo and certain new products, such as
Poppy & Barley from Jo Malone London and Metallique from Tom Ford.
•Our hair care net sales declined as COVID-19-related salon and retail closures
could not be offset by strong online acceleration. During fiscal 2020, Aveda
launched the hydrating Nutriplenish line of products, which contributed
positively.


                                       28
--------------------------------------------------------------------------------
  Table of Contents
Our global distribution capability and operations allow us to focus on targeted
expanded consumer reach wherever consumer demographics and trends are the most
attractive. Our regional organizations, and the expertise of our people there,
enable our brands to be more locally and culturally relevant in both product
assortment and communications. We are evolving the way we connect with our
consumers in stores, online and where they travel, including by expanding our
digital and social media presence and the engagement of global and local
influencers to amplify brand or product stories. We tailor our strategy by
market to drive consumer engagement and embrace cultural diversity. We
continuously strengthen our presence in large, image-building core markets,
while broadening our presence in emerging markets.

•In North America, we deployed a number of strategies to accelerate growth,
which began to deliver improvements through the first half of fiscal 2020.
However, the impact of COVID-19-related store closures in the latter half
further aggravated the challenging environment in brick-and-mortar retail.
Despite the overall decline in net sales, online net sales in North America grew
double digits. In Latin America, we continue to launch new brands, expand social
media outreach and encourage consumers to trade up from mass beauty products.
•In Europe, the Middle East & Africa, we are expanding the consumer reach of
many of our brands and strengthening their digital and social media presences.
•In Asia/Pacific, particularly in China, we are leveraging our diversified brand
portfolio and expansion on third-party online malls to benefit from the strong
consumer demand for prestige beauty. In mainland China, net sales grew strong
double digits reflecting growth in virtually all product categories, as well as
in nearly every brand and double-digit growth in every channel, led by online.
For fiscal 2020, over 40% of mainland China's net sales was contributed by our
online channels.

We approach distribution strategically by product category and location and seek
to optimize distribution by matching our brands with appropriate opportunities
while seeking to maintain high productivity per door. We are expanding our
brands in online and travel retail, which we believe will be higher growth
channels in the long term. We also focus on brand-building retail activities,
technology-driven activations and omnichannel capabilities that enhance the
shopping experience for consumers.

•As part of this strategy, we have built a leadership position in the global
travel retail channel, that allowed us to leverage the increase in international
passenger traffic before COVID-19. While COVID-19 has significantly curtailed
international travel in the near-term, we continue to believe it is a growth
opportunity for the long-term. Travel retail continues to be an important
channel for brand building due to the increase in traveling consumers,
particularly those from emerging markets, who often experience our brands for
the first time while traveling. We continue to expand our strategic presence in
travel retail across duty-free locations primarily in airports and downtown
stores. We engage consumers at the airport through compelling pop-up activations
in non-traditional commercial areas, and we ensure we have appropriate
communication and curated assortments for targeted consumer groups. At the same
time, travel retail is susceptible to a number of external factors, including
fluctuations in currency exchange rates and consumers' willingness and ability
to travel and spend.
•Online net sales have accelerated strongly on a global basis, reflecting strong
double digit growth for fiscal 2020, as well as growth in all product categories
and from nearly every brand. We continue to enhance and launch e- and m-commerce
sites of our own in new and existing markets, collaborate with our retail
customers on their e- and m-commerce sites, and sell through select third-party
online malls. We believe our success in delivering particularly strong online
growth is a result of adapting our strategy to meet local market and cultural
needs. We also continue to develop and implement omnichannel concepts, virtual
try-on tools and compelling content to deliver an integrated consumer experience
and better serve consumers as they shop across channels.

Our multiple engines of growth, which have historically enabled us to produce
excellent net sales growth, are also helping to mitigate the impact of the
declines caused by COVID-19. We also benefited from the transformation of
certain operations that freed up resources to invest behind further growth
opportunities. Our Leading Beauty Forward initiative (described below) enabled
us to reduce costs and invest in new capabilities such as digital marketing and
data analytics as well as increased advertising.

In fiscal 2020, we continued to further integrate corporate citizenship and
sustainability into our strategy and business operations. Areas of focus include
packaging, ingredient transparency, responsible sourcing, energy and emissions,
waste and water, social investments and employee engagement and safety.


                                       29
--------------------------------------------------------------------------------
  Table of Contents
Outlook

There are no comparable recent events that provide guidance concerning the
impacts of a global pandemic like COVID-19. Due to the uncertainty of its
duration and severity, at this time we are not able to reliably estimate to the
same degree as prior to COVID-19 the extent of the future adverse impact on our
financial condition or results of operations for fiscal 2021. The degree to
which COVID-19 and its collateral effects impact our business, the results of
operations and financial condition will depend on future developments that are
highly uncertain and cannot be predicted, including how quickly and to what
extent there are sustainable improvements in the retail environment and general
economic conditions. As we continue to monitor COVID-19 developments, including
the impacts on our consumers, customers and suppliers, we may adjust prior
actions and take further actions. However, there is no certainty that the
actions we take will be sufficient to mitigate the risks and impacts from
COVID-19.

We believe that the best way to increase long-term stockholder value is to
continue providing superior products and services in the most efficient and
effective manner while recognizing shifts in consumers' behaviors and shopping
practices. Accordingly, our long-term strategy has numerous initiatives across
geographic regions, product categories, brands, channels of distribution and
functions designed to grow our sales, provide cost efficiencies, leverage our
strengths and make us more productive and profitable. We plan to build upon and
leverage our history of outstanding creativity and innovation, high quality
products and services, and engaging communications while investing for long-term
sustainable growth.

While we continue to face strong competition and economic challenges globally,
COVID-19 has caused a more significant disruption to our business and the retail
industry generally. We are seeing, and believe there will be more impairments,
restructurings and bankruptcies in the retail industry, including among our
customers; destocking and tighter working capital management by retailers;
challenges for suppliers; and an acceleration in the shifts in consumer
preferences as to where and how they shop, as well as changes in their
preferences for certain products. The severe decline in international travel is
also causing a significant decline in our travel retail business, which had been
historically one of our most profitable channels. In addition to impacting net
sales and profitability, these and other challenges may impact our ability to
collect receivables and our operating cash flows generally and may adversely
impact the goodwill, other intangibles and long-lived assets associated with our
acquired brands. We continue to monitor the geopolitical tensions between the
United States and China and the uncertainties caused by the evolving trade
policy dispute, which could increase our cost of sales and negatively impact our
overall net sales, or otherwise have a material adverse effect on our business.
We also continue to monitor the potential implications of the ongoing economic
and political uncertainties stemming from the United Kingdom's exit and
transition from the European Union (i.e. "Brexit") and continue developing our
risk mitigation strategies to address such uncertainties. These strategies
include changes related to regulatory and legislative compliance, assessing
alternatives to supply chain routing, revising customer arrangements and
analyzing inventory levels.

We are also cautious of foreign currency movements, including their impacts on
tourism dynamics that have already been adversely affected by COVID-19 and
COVID-19 Directives. Additionally, we continue to monitor the effects of the
global macroeconomic environment; social and political issues; regulatory
matters, including the imposition of tariffs; geopolitical tensions; and global
security issues.

COVID-19 is proving to be the most significant challenge we have faced as a
public company. The uncertainty around the timing, speed and duration of the
recovery from the adverse impacts will continue to affect our ability to grow
sales profitably. We believe we can, to some extent, offset the impact of more
ordinary challenges by continually developing and pursuing a diversified
strategy with multiple engines of growth and by accelerating initiatives focused
on areas of strength, discipline and agility. As the current situation
progresses, if economic and social conditions or the degree of uncertainty or
volatility worsen, or the adverse conditions previously described are further
prolonged, there could be a further negative effect on consumer confidence,
demand, spending and willingness or ability to travel and, as a result, on our
business. We are continuing to monitor these and other risks that may affect our
business.

Leading Beauty Forward
In May 2016, we announced a multi-year initiative ("Leading Beauty Forward," or
the "LBF Program") to build on our strengths and better leverage our cost
structure to free resources for investment to continue our growth
momentum. Leading Beauty Forward is designed to enhance our go-to-market
capabilities, reinforce our leadership in global prestige beauty and continue
creating sustainable value. As of June 30, 2019, we concluded the approvals of
all major initiatives under Leading Beauty Forward related to the optimization
of select corporate functions, supply chain activities, and corporate and
regional market support structures, as well as the exit of underperforming
businesses, and expect to substantially complete those initiatives through
fiscal 2021. For additional information about restructuring and other charges,
see Item 8. Financial Statements and Supplementary Data - Note 8 - Charges
Associated with Restructuring and Other Activities.
                                       30
--------------------------------------------------------------------------------
  Table of Contents
Post-COVID Business Acceleration Program
On August 20, 2020, we announced a two-year restructuring program, Post-COVID
Business Acceleration Program (the "Restructuring Program"), designed to resize
our business against the dramatic shifts to our distribution landscape and
consumer behaviors in the wake of the COVID-19 pandemic. The Restructuring
Program will help improve efficiency and effectiveness by rebalancing resources
to growth areas of prestige beauty. It will further strengthen us by building
upon the foundational capabilities in which we have invested.

The Restructuring Program's main areas of focus include accelerating the shift
to online with the realignment of our distribution network reflecting
freestanding store and certain department store closures, with a focus on North
America and Europe, the Middle East & Africa; the reduction in brick-and-mortar
point of sale employees and related support staff; and the redesign of our
regional branded marketing organizations, plus select opportunities in global
brands and functions. We committed to this course of action on August 18, 2020.
This program is expected to position us to better execute our long-term strategy
while strengthening our financial flexibility.

In connection with the Restructuring Program, at this time we estimate a net
reduction in the range of approximately 1,500 to 2,000 positions globally, which
is about 3% of our current workforce including temporary and part-time
employees. This reduction takes into account the elimination of some positions,
retraining and redeployment of certain employees and investment in new positions
in key areas. We also estimate the closure of approximately 10% to 15% of our
freestanding stores globally.

We plan to approve specific initiatives under the Restructuring Program through
fiscal 2022 and expect to complete those initiatives through fiscal 2023. We
expect that the Restructuring Program will result in related restructuring and
other charges totaling between $400 million and $500 million, before taxes,
consisting of employee-related costs, contract terminations, asset write-offs
and other costs to implement these initiatives.

Once fully implemented, we expect the Restructuring Program to yield annual
benefits, primarily in selling, general and administrative expenses, of between
$300 million and $400 million, before taxes. We expect to reinvest a portion
behind future growth initiatives.

Impairment Testing



We assess goodwill and other indefinite-lived intangible assets at least
annually for impairment or more frequently if certain events or circumstances
exist.
During December 2019, given the continuing declines in prestige makeup,
generally in North America, and the ongoing competitive activity, our Too Faced,
BECCA and Smashbox reporting units made revisions to their internal forecasts
concurrent with our brand strategy review process. During March 2020, given the
actual and the estimate of the potential future impacts relating to the
uncertainty of the duration and severity of COVID-19 impacting us, we made
additional revisions to the internal forecasts relating to our Too Faced, BECCA,
Smashbox and GLAMGLOW reporting units. We concluded that the changes in
circumstances in these reporting units triggered the need for an interim
impairment review of their respective trademarks and goodwill. These changes in
circumstances were also an indicator that the carrying amounts of their
respective long-lived assets, including customer lists, may not be recoverable.
Accordingly, we performed interim impairment tests for the trademarks and
recoverability tests for the long-lived assets as of December 31, 2019 and March
31, 2020. We concluded that the carrying amounts of the long-lived assets were
recoverable. For December 31, 2019 and March 31, 2020, we also concluded that
the carrying values of the trademarks exceeded their estimated fair values and
recorded impairment charges. For December 31, 2019, we utilized the
relief-from-royalty method to determine discounted projected future cash flows,
and for March 31, 2020, the relief-from-royalty method was based on probability
weighted cash flows. After adjusting the carrying values of the trademarks, we
completed interim quantitative impairment tests for goodwill and recorded
goodwill impairment charges for each of these reporting units. For December 31,
2019, the fair value of each reporting unit was based upon an equal weighting of
the income and market approaches, utilizing estimated cash flows and a terminal
value, discounted at a rate of return that reflects the relative risk of the
cash flows, as well as valuation multiples derived from comparable publicly
traded companies that are applied to operating performance of the reporting
unit. For March 31, 2020, the fair value of each reporting unit was based upon
an equal weighting of the income and market approaches, utilizing estimated cash
flows, based on probability weighted undiscounted cash flows, and a terminal
value, discounted at a rate of return that reflects the relative risk of the
cash flows, as well as valuation multiples derived from comparable publicly
traded companies that are applied to operating performance of the reporting
unit.


                                       31
--------------------------------------------------------------------------------
  Table of Contents
Based on our annual goodwill and other indefinite-lived intangible asset
impairment testing as of April 1, 2020, we determined that the carrying value of
the Editions de Parfums Frédéric Malle reporting unit exceeded its fair value.
This determination was made based on updated internal forecasts, finalized and
approved in June 2020, that reflected lower net sales growth projections due to
a softer than expected retail environment for the brand, as well as the impacts
relating to the uncertainty of the duration and severity of COVID-19. These
changes in circumstances were also an indicator that the carrying amounts of its
respective long-lived assets, including customer lists, may not be recoverable.
We concluded that the carrying value of the trademarks exceeded its estimated
fair value, which was determined utilizing the relief-from-royalty method to
determine discounted projected future cash flows, and recorded impairment
charges. We concluded that the carrying amounts of the long-lived assets were
recoverable. After adjusting the carrying value of the trademarks, we completed
the quantitative impairment test for goodwill and recorded a goodwill impairment
charge for this reporting unit. The fair value of this reporting unit was based
upon an equal weighting of the income and market approaches, utilizing estimated
cash flows and a terminal value, discounted at a rate of return that reflects
the relative risk of the cash flows, as well as valuation multiples derived from
comparable publicly traded companies that are applied to operating performance
of the reporting unit.
During June 2020, given the actual and the estimate of the potential future
impacts relating to the uncertainty of the duration and severity of COVID-19
impacting us, we made further revisions to the internal forecasts relating to
our BECCA and GLAMGLOW reporting units. We concluded that the changes in
circumstances in these reporting units triggered the need for an interim
impairment review of their respective trademarks and goodwill. These changes in
circumstances were also an indicator that the carrying amounts of their
respective long-lived assets, including customer lists, may not be recoverable.
Accordingly, we performed interim impairment tests for the trademarks and
recoverability tests for the long-lived assets as of June 30, 2020. We concluded
that the carrying values of the trademarks for BECCA and GLAMGLOW exceeded their
estimated fair values, which were determined utilizing the relief-from-royalty
method to determine discounted projected future cash flows, and recorded
impairment charges. In addition, we concluded that the carrying value of the
BECCA customer lists intangible asset exceeded its estimated fair value, which
was determined utilizing the multi-period excess earnings income approach by
discounting the incremental after-tax cash flows over multiple periods, and
recorded an impairment charge. We concluded that the carrying amounts of the
long-lived assets of GLAMGLOW were recoverable. After adjusting the carrying
values of the trademarks and the BECCA customer lists, we completed interim
quantitative impairment tests for goodwill and recorded goodwill impairment
charges for each of these reporting units. The fair value of each reporting unit
was based upon an equal weighting of the income and market approaches, utilizing
estimated cash flows and a terminal value, discounted at a rate of return that
reflects the relative risk of the cash flows, as well as valuation multiples
derived from comparable publicly traded companies that are applied to operating
performance of the reporting unit.
A summary of the impairment charges for the three and twelve months ended
June 30, 2020 and the remaining trademark, customer lists and goodwill carrying
values as of June 30, 2020, for each reporting unit, are as follows:

                                                                                                             Impairment Charge
                                                                           Three Months Ended                                                                                              Twelve Months Ended
(In millions)                                                                 June 30, 2020                                                                                                   June 30, 2020                                                           Carrying Value
Reporting Unit:              Product Category             Trademark              Customer Lists          Goodwill           Trademark           Customer Lists            Goodwill             Trademark           Customer

Lists          Goodwill
Too Faced                  Makeup                     $        -               $             -          $      -          $      253          $             -          $     592             $      272          $           217          $     13
BECCA                      Makeup                             24                            35                15                  71                       35                 85                     27                        7                13
Smashbox                   Makeup                              -                             -                 -                  23                        -                 72                     32                        -                 -
GLAMGLOW                   Skin care                           5                             -                 8                   6                        -                 60                     57                        6                54
Editions de Parfums
Frédéric Malle             Fragrance                          11                             -                 3                  11                        -                  3                     21                        2                 3
Total                                                 $       40               $            35          $     26          $      364          $            35          $     812             $      409          $           232          $     83

The impairment charges for the three and twelve months ended June 30, 2020 were reflected in the Americas region.

With the exception of the Editions de Parfums Frédéric Malle, BECCA, and GLAMGLOW reporting units, fair values of all reporting units, which were primarily determined based on qualitative assessments, with material goodwill were substantially in excess of their respective carrying values.


                                       32
--------------------------------------------------------------------------------
  Table of Contents
The fair values of the Editions de Parfums Frédéric Malle, BECCA, and GLAMGLOW
trademarks were equal to their carrying values subsequent to the impairments
charges taken as of June 30, 2020, and the fair values of the Too Faced and
Smashbox trademarks exceeded their carrying values by approximately 7% and 16%,
respectively. As of June 30, 2020, the carrying values of the Too Faced and
Smashbox trademarks were $272 million and $32 million, respectively. The key
assumptions used to determine the estimated fair value of the reporting units
are primarily predicated on the estimated future impacts of COVID-19, the
success of future new product launches, the achievement of distribution
expansion plans, and the realization of cost reduction and other efficiency
efforts. If such plans do not materialize, or if there are further challenges in
the business environments in which these reporting units operate, resulting
changes in the key assumptions could have negative impacts on the estimated fair
values of the reporting units and it is possible we could recognize additional
impairment charges in the future.
For additional information, see Item 8. Financial Statements and Supplementary
Data - Note 6 - Goodwill and Other Intangible Assets.
Fiscal 2019 as Compared with Fiscal 2018
See Item 7. Management's Discussion and Analysis of Financial Condition and
Results of Operations - Results of Operations of the Company's Annual Report on
Form 10-K for the fiscal year ended June 30, 2019 for the fiscal 2019 to fiscal
2018 comparative discussion.
Fiscal 2020 as Compared with Fiscal 2019
NET SALES
                                                       Year Ended June 30
($ in millions)                                       2020           2019
As Reported:
Net sales                                          $ 14,294       $ 14,863
$ Change from prior year                               (569)         1,180
% Change from prior year                                 (4) %           9  %

Non-GAAP Financial Measure(1):
% Change from prior year in constant currency            (3) %          11  %


(1)See Reconciliations of Non-GAAP Financial Measures beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



The fiscal 2020 decrease in reported net sales reflected declines in virtually
all product categories and geographic regions driven by the negative impacts, in
the second half of the fiscal year, of the COVID-19 pandemic, including our
response and the responses of others to COVID-19 Directives. These directives
included the temporary closing of businesses deemed "non-essential," travel bans
and restrictions, social distancing and quarantines. Skin care net sales growth
primarily reflected higher sales from Estée Lauder and La Mer, as well as
incremental net sales attributable to our acquisition of Dr. Jart+ at the end of
the fiscal 2020 second quarter. The increase in net sales in mainland China and
our travel retail business drove growth internationally. In addition, sales of
certain of our products online continued to accelerate. As noted above, the
impacts of COVID-19 caused significant disruptions to our business, and we
expect the results of operations of our product categories and regions to
continue to be adversely impacted in subsequent periods.

The fiscal 2020 reported net sales decrease was impacted by approximately
$154 million of unfavorable foreign currency translation.
Returns associated with restructuring and other activities are not allocated to
our product categories or geographic regions because they result from activities
that are deemed a Company-wide initiative to redesign, resize and reorganize
select corporate functions and go-to-market structures. Accordingly, the
following discussions of Net sales by Product Categories and Geographic Regions
exclude the fiscal 2019 impact of returns associated with restructuring and
other activities of approximately $3 million.

                                       33
--------------------------------------------------------------------------------

  Table of Contents
Skin Care
                                                       Year Ended June 30
($ in millions)                                        2020           2019
As Reported:
Net sales                                          $   7,382       $ 6,551
$ Change from prior year                                 831           956
% Change from prior year                                  13  %         17  %

Non-GAAP Financial Measure(1):
% Change from prior year in constant currency             14  %         20  %


(1)See Reconciliations of Non-GAAP Financial Measures beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



Reported skin care net sales increased in fiscal 2020, due to growth
internationally and reflected higher net sales from Estée Lauder and La Mer,
combined, of approximately $844 million, as well as incremental net sales of
$165 million attributable to our acquisition of Dr. Jart+ at the end of the
fiscal 2020 second quarter. Net sales increased from Estée Lauder, reflecting
the continued success of existing product franchises, such as Advanced Night
Repair, Perfectionist, Re-Nutriv and Revitalizing Supreme+, and new product
launches, such as Advanced Night Repair Intense Reset Concentrate. The increase
in net sales from La Mer reflected international growth, led by mainland China,
as well as our travel retail business due to Chinese traveling consumers. Net
sales from La Mer also benefited from existing products, such as The Treatment
Lotion, and product relaunches, such as The Regenerating Serum, as well as
targeted expanded consumer reach. Net sales increases from both Estée Lauder and
La Mer drove growth in our travel retail and online channels.

Partially offsetting these increases were lower net sales from Clinique and
M·A·C, combined, of approximately $191 million. Net sales declined from these
brands, reflecting lower net sales in all geographic regions due to the
challenging environment as a result of the COVID-19 pandemic. Despite the
overall decline in net sales, Clinique online net sales grew double digits.
The skin care net sales increase was impacted by approximately $77 million of
unfavorable foreign currency translation.
Makeup
                                                       Year Ended June 30
($ in millions)                                        2020           2019
As Reported:
Net sales                                          $   4,794       $ 5,860
$ Change from prior year                              (1,066)          227
% Change from prior year                                 (18) %          4  %

Non-GAAP Financial Measure(1):
% Change from prior year in constant currency            (17) %          7  %


(1)See Reconciliations of Non-GAAP Financial Measures beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



Reported makeup net sales decreased in fiscal 2020, primarily driven by lower
net sales from M·A·C, Clinique, Too Faced and Bobbi Brown, combined, of
approximately $886 million. The decrease in net sales from these brands
reflected declines in North America, due to the general decline in prestige
makeup and ongoing competitive activity, as well as the challenging environment
as a result of the COVID-19 pandemic. International net sales from these brands,
particularly in Europe, the Middle East & Africa, also reflected the challenging
environment caused by the COVID-19 pandemic, which negatively impacted the
second half of fiscal 2020.

The makeup net sales decrease was impacted by approximately $57 million of unfavorable foreign currency translation.


                                       34
--------------------------------------------------------------------------------

  Table of Contents
Fragrance
                                                       Year Ended June 30
($ in millions)                                        2020           2019
As Reported:
Net sales                                          $   1,563       $ 1,802
$ Change from prior year                                (239)          (24)
% Change from prior year                                 (13) %         (1) %

Non-GAAP Financial Measure(1):
% Change from prior year in constant currency            (12) %          1  %


(1)See Reconciliations of Non-GAAP Financial Measures beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



Reported fragrance net sales decreased in fiscal 2020, reflecting lower net
sales from certain of our designer fragrances, Estée Lauder and Jo Malone London
of approximately $188 million, combined. The lower net sales from certain
designer fragrances reflected a decline in North America, primarily due to the
challenging environment as a result of the COVID-19 pandemic, an unfavorable
comparison to the prior-year period as a result of the December 2019 expiration
of our license agreement with Tory Burch and higher launch activity in the prior
year. The net sales decline from Estée Lauder reflected lower net sales in all
geographic regions due to the challenging environment as a result of the
COVID-19 pandemic, as well as an unfavorable comparison to the prior-year launch
of Beautiful Belle in North America. Net sales declined from Jo Malone London
due to the fiscal 2020 fourth quarter impact of the COVID-19 pandemic, primarily
in our travel retail business as a result of the curtailment of air travel that
adversely impacted consumer traffic in most travel retail locations.

The fragrance net sales decrease was impacted by approximately $18 million of
unfavorable foreign currency translation.
Hair Care
                                                         Year Ended June 30
($ in millions)                                        2020                2019
As Reported:
Net sales                                          $    515              $ 584
$ Change from prior year                                (69)                14
% Change from prior year                                (12)  %              2  %

Non-GAAP Financial Measure(1):
% Change from prior year in constant currency           (11)  %             

4 %

(1)See Reconciliations of Non-GAAP Financial Measures beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



Reported hair care net sales decreased in fiscal 2020, due to lower net sales
from Aveda and Bumble and bumble. The lower net sales from Aveda was primarily
driven by a decline in retail traffic and salon and store closures, exacerbated
by the impacts of the COVID-19 pandemic. Net sales declined from Bumble and
bumble due to the softness in North America in the salon and specialty-multi
channels, as well as store closures in the second half of fiscal 2020 due to the
COVID-19 pandemic.

                                       35
--------------------------------------------------------------------------------

  Table of Contents
Geographic Regions
The Americas
                                                       Year Ended June 30
($ in millions)                                        2020           2019
As Reported:
Net sales                                          $   3,794       $ 4,741
$ Change from prior year                                (947)         (274)
% Change from prior year                                 (20) %         (5) %

Non-GAAP Financial Measure(1):
% Change from prior year in constant currency            (20) %         (5) %


(1)See Reconciliations of Non-GAAP Financial Measures beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



Reported net sales in The Americas decreased in fiscal 2020, due to lower net
sales in all countries, led by the United States of approximately $803 million,
due to the challenging environment caused by the COVID-19 pandemic, including
the temporary closing of brick-and-mortar retail stores, travel bans and
restrictions, social distancing and quarantines, which significantly impacted
the second half of fiscal 2020. The decrease in net sales in the United States
also reflected lower net sales from M·A·C, Clinique and Too Faced due to the
decline in prestige makeup generally in North America. Also contributing to the
decline was an unfavorable comparison to prior-year launch activity from certain
of our designer fragrances and Estée Lauder. Despite the overall decline in net
sales, online net sales in The Americas grew double digits.
Europe, the Middle East & Africa
                                                       Year Ended June 30
($ in millions)                                        2020           2019
As Reported:
Net sales                                          $   6,262       $ 6,452
$ Change from prior year                                (190)          818
% Change from prior year                                  (3) %         15  %

Non-GAAP Financial Measure(1):
% Change from prior year in constant currency             (2) %         18  %


(1)See Reconciliations of Non-GAAP Financial Measures beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



Reported net sales in Europe, the Middle East & Africa decreased in fiscal 2020,
reflecting lower net sales in virtually all markets, led by the United Kingdom
and the Western European markets, combined, of approximately $335 million, due
to the COVID-19 pandemic and its challenges across the region, including
temporary closing of brick-and-mortar retail stores, travel bans and
restrictions, social distancing and quarantines. In Europe, the Middle East &
Africa, all of our freestanding stores were closed in April 2020, and, despite
the gradual door re-openings throughout the quarter, including those of our
retailers, retail traffic was significantly reduced. While net sales from
brick-and-mortar retail stores were challenged, net sales from our online
channels grew double digits, as our beauty advisors shifted to Social Selling.
Net sales in the United Kingdom decreased due to the challenging environment
caused by the COVID-19 pandemic, as well as adverse macroeconomic conditions.
From March 2020 to mid-June 2020, our freestanding stores and those of our
retailers were closed due to the COVID-19 Directives discussed above. While
gradual door re-openings began in mid-June 2020, retail traffic remained slow.
Despite the challenges in brick-and-mortar retail stores, net sales from our
online channels grew strong double digits.

                                       36
--------------------------------------------------------------------------------
  Table of Contents
Partially offsetting these decreases was an increase in net sales from our
travel retail business of approximately $261 million. While challenged in the
second half of fiscal 2020, due to the global airport closures and travel bans
and restrictions caused by the COVID-19 pandemic, our travel retail business
delivered strong results in the first half of fiscal 2020. Net sales in travel
retail increased, primarily from Estée Lauder, reflecting the strength of
certain of our hero products, such as Advanced Night Repair, and the shift in
consumer preferences to skin care products from other product categories, in
part, as a result of the COVID-19 pandemic. This was partially offset by
decreases in net sales from M·A·C, Tom Ford and Clinique.
The net sales decrease in Europe, the Middle East & Africa included
approximately $67 million of unfavorable foreign currency translation.
Asia/Pacific
                                                       Year Ended June 30
($ in millions)                                        2020           2019
As Reported:
Net sales                                          $   4,238       $ 3,673
$ Change from prior year                                 565           631
% Change from prior year                                  15  %         21  %

Non-GAAP Financial Measure(1):
% Change from prior year in constant currency             18  %         25  %


(1)See Reconciliations of Non-GAAP Financial Measures beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



Reported net sales in Asia/Pacific increased in fiscal 2020, reflecting higher
net sales in mainland China and Korea of approximately $822 million, combined.
The higher net sales in mainland China reflected strong double-digit growth from
virtually every brand, led by Estée Lauder, La Mer, Tom Ford and M·A·C;
incremental net sales attributable to our acquisition of Dr. Jart+ at the end of
the fiscal 2020 second quarter; continued growth in skin care and makeup;
targeted expanded consumer reach; and the success of new product launches, such
as Estée Lauder's Advanced Night Repair Intense Reset Concentrate and a new
larger size of The Treatment Lotion from La Mer. The net sales increase in
mainland China benefited virtually all channels, led by online (due in part to
successful holiday events and campaigns on Tmall) and department stores. The net
sales growth in Korea primarily reflected incremental net sales attributable to
our acquisition of Dr. Jart+ in the second quarter, including net sales of Dr.
Jart+ products in the travel retail channel. These increases were partially
offset by lower net sales in Hong Kong of approximately $203 million, due to the
pre-COVID-19 protests there that negatively impacted traffic in downtown shops
and the airport and also led to intermittent store closures. Our business in the
second half of the fiscal year, in Hong Kong and elsewhere in Asia/Pacific, was
adversely impacted by challenges attributable to the COVID-19 pandemic discussed
above.
The net sales increase in Asia/Pacific included approximately $89 million of
unfavorable foreign currency translation.
We strategically time our new product launches by geographic market, which may
account for differences in regional sales growth.

                                       37
--------------------------------------------------------------------------------
  Table of Contents
GROSS MARGIN
Gross margin in fiscal 2020 decreased to 75.2% as compared with 77.2% in fiscal
2019.
                                                                        Fiscal 2020 vs. Fiscal 2019
                                                                       Favorable (Unfavorable) Basis
                                                                                  Points
Mix of business                                                                            20
Obsolescence charges                                                                     (115)
Foreign exchange transactions                                                              15
Manufacturing costs and other                                                            (140)
Subtotal                                                                                 (220)
Charges associated with restructuring and other activities                                 20
Total                                                                                    (200)



The decrease in gross margin for fiscal 2020 in manufacturing costs and other
reflected the timing of expense recognition and costs incurred as a result of
the COVID-19 pandemic, including the shutdown of certain of our manufacturing
facilities and the implementation of social distancing measures, of $83 million,
or approximately 60 basis points; the increase in demand in certain Asian
markets that caused an increase in freight, transportation and other
manufacturing costs; the unfavorable impacts of incremental tariffs; and higher
cost of sales related to our fiscal 2020 acquisition of Dr. Jart+, which
includes an inventory step-up adjustment of $25 million, or approximately 20
basis points. Also reflected in the decrease in gross margin are obsolescence
charges due to the increase in excess and obsolete inventory of $166 million or
115 basis points, of which $33 million, or approximately 20 basis points, was
caused by the impact of the COVID-19 pandemic.

OPERATING EXPENSES Operating expenses as a percentage of net sales in fiscal 2020 increased to 70.9% as compared with 61.6% in fiscal 2019.


                                                                         Fiscal 2020 vs. Fiscal 2019
                                                                        Favorable (Unfavorable) Basis
                                                                                   Points
General and administrative expenses                                                        (40)
Advertising, merchandising, sampling and product development                               (80)
Selling                                                                                     50
Shipping                                                                                   (20)
Store operating costs                                                                      (20)
Stock-based compensation                                                                    10
Foreign exchange transactions                                                               30
Subtotal                                                                                   (70)
Charges associated with restructuring and other activities                                  90
Changes in fair value of contingent consideration                                          (10)
Goodwill, other intangible and long-lived asset impairments                               (940)
Total                                                                                     (930)



The fiscal 2020 operating expenses as a percent of net sales increased compared
to fiscal 2019 driven by the impact of goodwill, other intangible and long-lived
asset impairments. In addition, advertising and promotional activities increased
to support new product launches, digital spending, social media and targeted
expanded consumer reach, primarily in mainland China. The increase in general
and administrative expenses reflected higher professional service fees,
investments in information systems and to support our sustainability
initiatives, as well as amortization expense relating to the acquired intangible
assets of Dr. Jart+. Partially offsetting these increases was a decrease in
selling expense due to the reduction in employee costs as a result of the
COVID-19 government assistance, and a decrease in general and administrative
expenses due to the decrease in accrued employee incentive compensation as a
result of the COVID-19 impacts on fiscal 2020.
                                       38
--------------------------------------------------------------------------------
  Table of Contents
As the impacts from COVID-19 evolved, we faced various uncertainties and
implemented strict cost control measures. They included furloughs and similar
unpaid temporary leaves of absence for many point of sale employees; temporary
salary reductions for senior executives and other management employees; a
temporary elimination of cash retainers for the Board of Directors; and expanded
cost control measures (e.g., advertising and promotion activities, travel,
meetings and consulting), the majority of which began in May 2020.

OPERATING RESULTS
                                                                            Year Ended June 30
($ in millions)                                                           2020                2019
As Reported:
Operating income                                                     $      606           $   2,313
$ Change from prior year                                                 (1,707)                258
% Change from prior year                                                    (74)  %              13  %

Operating Margin                                                            4.2   %            15.6  %

Non-GAAP Financial Measure(1): % Change in operating income from prior year adjusting for the impact of charges associated with restructuring and other activities, goodwill, other intangible and long-lived asset impairments and changes in fair value of contingent consideration

                                                               (20)  %              15  %


(1)See Reconciliations of Non-GAAP Financial Measures beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



The reported operating margin for fiscal 2020 decreased from the prior year
driven primarily by the year-over-year impact of goodwill, other intangible and
long-lived asset impairments of $1,426 million, or 940 bps and the decrease in
gross margin, as previously noted. Partially offsetting these impacts were the
acceleration of online net sales growth and disciplined expense management
throughout the business from cost containment actions taken in response to
COVID-19.

The fiscal 2020 goodwill, intangible and long-lived asset impairments and the
changes in fair value of contingent consideration impacted the operating results
of our product categories and geographic regions as follows:

                                                          Year ended                                                                                                               Year ended
                                                        June 30, 2020                                                                                                            June 30, 2019
                                                               Goodwill,                                                                   Goodwill,                                  Year-over-year net
                                 Changes in fair           other intangible                                 Changes in fair            other intangible                                     impact
                               value of contingent          and long-lived                                value of contingent           and long-lived                                    favorable
(In millions)                     consideration            asset impairments         Net Impact              consideration             asset impairments         Net Impact             (unfavorable)
Product Category:
Skin Care                    $                  7          $          (88)         $       (81)         $                 25          $              -          $       25          $              (106)
Makeup                                          -                  (1,291)              (1,291)                            -                       (90)                (90)                      (1,201)
Fragrance                                      10                     (32)                 (22)                           12                         -                  12                          (34)
Hair Care                                       -                     (14)                 (14)                            -                         -                   -                          (14)
Other                                           -                      (1)                  (1)                            -                         -                   -                           (1)
Total                        $                 17          $       (1,426)         $    (1,409)         $                 37          $            (90)         $      (53)         $            (1,356)

Region:
The Americas                 $                  7          $       (1,314)         $    (1,307)         $                 27          $            (90)         $      (63)         $            (1,244)
Europe, the Middle
East & Africa                                  10                    (104)                 (94)                           10                         -                  10                         (104)
Asia/Pacific                                    -                      (8)                  (8)                            -                         -                   -                           (8)
Total                        $                 17          $       (1,426)         $    (1,409)         $                 37          $            (90)         $      (53)         $            (1,356)



                                       39

--------------------------------------------------------------------------------
  Table of Contents
Charges associated with restructuring and other activities are not allocated to
our product categories or geographic regions because they result from activities
that are deemed a Company-wide initiative to redesign, resize and reorganize
select corporate functions and go-to-market structures. Accordingly, the
following discussions of Operating income by Product Categories and Geographic
Regions exclude the fiscal 2020 and 2019 impact of charges associated with
restructuring and other activities of $83 million, or 1% of net sales and $241
million, or 2% of net sales, respectively.

Product Categories
Skin Care
                                                                            Year Ended June 30
($ in millions)                                                          2020                2019
As Reported:
Operating income                                                     $    2,125          $   1,925
$ Change from prior year                                                    200                411
% Change from prior year                                                     10  %              27  %

Non-GAAP Financial Measure(1): % Change in operating income from prior year adjusting for the impact of goodwill, other intangible and long-lived asset impairments and changes in fair value of contingent consideration

                                                                16  %              27  %


(1)See "Reconciliations of Non-GAAP Financial Measures" beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



Reported skin care operating income increased in fiscal 2020, driven by higher
results from Estée Lauder and La Mer, combined, of approximately $514 million.
The increases in operating income reflected higher net sales, partially offset
by strategic investments in advertising and promotional activities and targeted
expanded consumer reach. The increase in skin care operating income also
reflected the decrease in accrued employee incentive compensation as a result of
the COVID-19 impacts on fiscal 2020, as well as the reduction in selling expense
due, in part, to the COVID-19 government assistance programs discussed above.
Partially offsetting these increases were lower results from Clinique and
GLAMGLOW, combined, of approximately $179 million. The lower results from
Clinique reflected the decline in net sales. Operating results from GLAMGLOW
decreased primarily due to the impact of the current year goodwill and other
intangible asset impairments and the change in fair value of contingent
consideration of $83 million, combined. Also reflected in the decrease in
reported skin care operating results is the impact of freestanding store
long-lived asset impairments relating to COVID-19 of $22 million, as well as the
increase in cost of sales due, in part, to the timing of expense recognition and
costs incurred as a result of the COVID-19 pandemic.
Makeup
                                                                             Year Ended June 30
($ in millions)                                                           2020                  2019
As Reported:
Operating income                                                    $    (1,438)            $     438
$ Change from prior year                                                 (1,876)                 (111)
% Change from prior year                                                      (100+)%             (20) %

Non-GAAP Financial Measure(1): % Change in operating income from the prior-year period adjusting for the impact of goodwill, other intangible and long-lived asset impairments

                                                  (100+)%              (4) %


(1)See "Reconciliations of Non-GAAP Financial Measures" beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.


                                       40
--------------------------------------------------------------------------------
  Table of Contents
Reported makeup operating results decreased in fiscal 2020, driven by lower
results from Too Faced, M·A·C and BECCA, combined, of approximately $1,527
million. The fiscal 2020 operating results from Too Faced and BECCA include $845
million and $191 million of goodwill and other intangible asset impairments,
respectively. The decrease in operating results from these brands also reflects
the decrease in net sales due to the general decline in prestige makeup and
ongoing competitive activity in North America, as well as the challenging
environment as of COVID-19. The lower results from M·A·C were driven by the
decrease in net sales as discussed above. Also reflected in the decrease in
reported makeup operating results is the impact of freestanding store long-lived
asset impairments relating to COVID-19 of $160 million.
Partially offsetting the decrease in operating results was the reduction in
selling expense due, in part, to the COVID-19 government assistance programs
discussed above and the decrease in accrued employee incentive compensation as a
result of the COVID-19 impact on fiscal 2020.

Fragrance
                                                                            Year Ended June 30
($ in millions)                                                           2020                2019
As Reported:
Operating income                                                     $       17           $     140
$ Change from prior year                                                   (123)                (36)
% Change from prior year                                                    (88)  %             (20) %

Non-GAAP Financial Measure(1): % Change in operating income from prior year adjusting for the impact of long-lived asset impairments and changes in fair value of contingent consideration

                                           (70)  %             (17) %


(1)See "Reconciliations of Non-GAAP Financial Measures" beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



Reported fragrance operating income decreased in fiscal 2020, driven by lower
results from Jo Malone London, certain of our designer fragrances, Editions de
Parfums Frédéric Malle and Clinique of approximately $104 million, combined. The
lower results from Jo Malone London, certain of our designer fragrances and
Clinique were driven by the decreases in net sales. Operating results from
Editions de Parfums Frédéric Malle decreased primarily due to the impact of the
current year goodwill and other intangible asset impairments and the change in
fair value of contingent consideration of $16 million, combined. Also reflected
in the decrease in reported fragrance operating results is the impact of
freestanding store long-lived asset impairments relating to COVID-19 of $18
million. Partially offsetting the decrease in net sales from certain of our
designer fragrances was disciplined expense management.
Hair Care
                                     Year Ended June 30
($ in millions)                        2020             2019
As Reported:
Operating income               $      (19)             $ 39
$ Change from prior year              (58)              (25)
% Change from prior year                    (100+)%     (39) %



Reported hair care operating results decreased in fiscal 2020, reflecting lower
results from Aveda and Bumble and bumble driven primarily by the decrease in net
sales. Also reflected in the decrease in reported hair care operating results is
the impact of freestanding store long-lived asset impairments relating to
COVID-19 of $14 million.

                                       41
--------------------------------------------------------------------------------

  Table of Contents
Geographic Regions
The Americas
                                                                                  Year Ended June 30
($ in millions)                                                                 2020                2019
As Reported:
Operating income                                                           $    (1,044)         $     672
$ Change from prior year                                                        (1,716)              (200)
% Change from prior year                                                          (100+)%             (23) %

Non-GAAP Financial Measure(1): % Change in operating income from prior year adjusting for the impact of goodwill, other intangible and long-lived asset impairments and changes in fair value of contingent consideration

                  (64) %             (13) %


(1)See "Reconciliations of Non-GAAP Financial Measures" beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



Reported operating results in The Americas decreased in fiscal 2020, primarily
due to the year-over-year impact of goodwill, other intangible and freestanding
store long-lived asset impairments and the change in fair value of contingent
consideration of $1,244 million, as well as lower net sales.
Partially offsetting the decrease in operating results was disciplined expense
management, the decrease in accrued employee incentive compensation as a result
of the COVID-19 impact on fiscal 2020 and the reduction in selling expense due,
in part, to the COVID-19 government assistance programs as discussed above.

To conform with the current year methodology and presentation, reported operating income in The Americas for fiscal 2019 was adjusted to include intercompany royalty income, reflecting the value created in The Americas, given the growth of our travel retail business.

Europe, the Middle East & Africa


                                                                            Year Ended June 30
($ in millions)                                                           2020                2019
As Reported:
Operating income                                                     $      997           $   1,153
$ Change from prior year                                                   (156)                288
% Change from prior year                                                    (14)  %              33  %

Non-GAAP Financial Measure(1): % Change in operating income from prior year adjusting for the impact of long-lived asset impairments and changes in fair value of contingent consideration

                                            (5)  %              34  %


(1)See "Reconciliations of Non-GAAP Financial Measures" beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.



Reported operating results in Europe, the Middle East & Africa decreased in
fiscal 2020, primarily due to the decrease in net sales, as discussed above, and
freestanding store long-lived asset impairments of $104 million. Partially
offsetting these decreases was higher results from our travel retail business,
reflecting the increase in net sales as discussed above.
To conform with the current year methodology and presentation, reported
operating income in Europe, the Middle East & Africa for fiscal 2019 was
adjusted to include intercompany royalties to The Americas, discussed above.

                                       42
--------------------------------------------------------------------------------

  Table of Contents
Asia/Pacific
                                     Year Ended June 30
($ in millions)                    2020                2019
As Reported:
Operating income               $    736              $ 729
$ Change from prior year              7                154
% Change from prior year              1   %             27  %



Reported operating income in Asia/Pacific increased slightly in fiscal 2020,
reflecting higher results in mainland China of approximately $160 million driven
by net sales growth. The net sales increases in mainland China were partially
offset by an increase in advertising and promotional activities to support
digital advertising, social media and targeted expanded consumer reach. The
growth in operating income was partially offset by lower results in Hong Kong,
Japan and Australia, combined, of approximately $140 million. The decreases in
operating income were driven by lower net sales, partially offset by disciplined
expense management.
INTEREST AND INVESTMENT INCOME
                                                      Year Ended June 30
(In millions)                                           2020             2019
Interest expense                                $      161              $ 133
Interest income and investment income, net      $       48              $  

58





Interest expense increased in fiscal 2020 primarily due to the issuance of
additional long-term debt in November 2019 and April 2020.
Interest income and investment income, net decreased in fiscal 2020, primarily
due to lower interest rates.
OTHER INCOME, NET
On December 18, 2019, we acquired the remaining equity interest in Have&Be Co.
Ltd. ("Have & Be"), the global skin care company behind Dr. Jart+ and men's
grooming brand Do The Right Thing, for $1,268 million in cash. Based on the
final purchase price and working capital adjustments, we estimated a refund
receivable of $32 million that was still outstanding as of June 30, 2020, and
was subsequently received in August 2020. We originally acquired a minority
interest in Have & Be in December 2015, which included a formula-based call
option for the remaining equity interest. The original minority interest was
accounted for as an equity method investment, which had a carrying value of $133
million at the acquisition date. The acquisition of the remaining equity
interest in Have & Be was considered a step acquisition, whereby we remeasured
the previously held equity method investment to its fair value. The acquisition
of the remaining equity interest also resulted in the recognition of a
previously unrealized foreign currency gain, which was reclassified from
accumulated OCI. The total gain on our previously held equity method investment
is reflected in Other income, net for the year ended June 30, 2020.
The amount paid at closing was funded by cash on hand including the proceeds
from the issuance of debt. In anticipation of the closing, we transferred cash
to a foreign subsidiary for purposes of making the closing payment. As a result,
we recognized a foreign currency gain, which is also included in Other income,
net for the year ended June 30, 2020.

                                       43
--------------------------------------------------------------------------------
  Table of Contents
A summary of the total purchase price and the total gain recognized in Other
income, net in the consolidated statements of earnings is as follows:

                                                                              Measurement Period
(In millions)                                   December 18, 2019                 Adjustments               June 30, 2020
Purchase price
Purchase price                             $                  1,268          $              (32)         $           1,236
Fair value of previously held equity
method investment                                               682                         (22)                       660
Write-off of call option relating to
previously held equity method
investment                                                        4                           -                          4
Total purchase price                       $                  1,954          $              (54)         $           1,900

                                            For the Six Months Ended          Measurement Period          For the Year Ended
                                                December 31, 2019                 Adjustments               June 30, 2020
Gains recognized in the consolidated
statement of earnings
Gain on previously held equity
method investment                          $                    549          $              (19)         $             530
Recognition of a previously
unrealized foreign currency gain                                  4                           -                          4
Total gain on previously held equity
method investment                                               553                         (19)                       534

Foreign currency gain on cash                                    23                           -                         23
Total Other income, net                    $                    576          $              (19)         $             557


See Item 8. Financial Statements and Supplementary Data - Note 5 - Acquisition of Business for additional information.



The Tax Cuts and Jobs Act (the "TCJA"), which was enacted on December 22, 2017,
presented us with opportunities to manage cash and investments more efficiently
on a global basis. Accordingly, during fiscal 2019, as part of the assessment of
those opportunities, we sold our available-for-sale securities, which liquidated
our investment in the foreign subsidiary that owned those securities. As a
result, we recorded a realized foreign currency gain on liquidation of $77
million and a gross loss on the sale of available-for-sale securities of $6
million, both of which were reclassified from accumulated OCI and are reflected
in Other income, net for the year ended June 30, 2019. See Item 8. Financial
Statements and Supplementary Data - Note 2 - Summary of Significant Accounting
Policies - Currency Translation and Transactions for further information.
PROVISION FOR INCOME TAXES
The provision for income taxes represents U.S. federal, foreign, state and local
income taxes. The effective rate differs from the federal statutory rate
primarily due to the effect of state and local income taxes, the tax impact of
share-based compensation, the taxation of foreign income and income tax reserve
adjustments, which represent changes in our net liability for unrecognized tax
benefits including tax settlements and lapses of the applicable statutes of
limitations. Our effective tax rate will change from quarter to quarter based on
recurring and non-recurring factors including the geographical mix of earnings,
enacted tax legislation, state and local income taxes, tax reserve adjustments,
the tax impact of share-based compensation and the interaction of various global
tax strategies. In addition, changes in judgment from the evaluation of new
information resulting in the recognition, derecognition or remeasurement of a
tax position taken in a prior annual period are recognized separately in the
quarter of change.
                                       44
--------------------------------------------------------------------------------
  Table of Contents
The TCJA included broad and complex changes to the U.S. tax code that impacted
our accounting and reporting for income taxes. See Item 8. Financial Statements
and Supplementary Data - Note 9 - Income Taxes for further discussion relating
to the TCJA.
                                                Year Ended June 30
                                                2020           2019
Earnings before income taxes:               $   1,046       $ 2,307

As Reported:
Effective rate for income taxes                  33.5  %       22.2  %
Basis-point change from prior year(1)           1,130        (2,140)

Non-GAAP Financial Measure(2):
Effective rate for income taxes                  23.2  %       21.5  %


(1)The basis point changes in our effective tax rate were materially impacted by
the decrease in earnings before income taxes from fiscal 2019 to fiscal 2020.
(2)Fiscal 2020 and 2019 effective tax rates exclude the net impact on the
effective tax rates of charges associated with restructuring and other
activities, goodwill and other intangible asset impairments, other income, net
and changes in the fair value of contingent consideration. Fiscal 2020 also
excludes the impact of long-lived asset impairments. Fiscal 2019 was also
adjusted to exclude the finalization of the TCJA provisional charges recorded in
fiscal 2018.

The effective tax rate for fiscal 2020 increased approximately 1,130 basis
points. The increase was primarily attributable to a higher effective tax rate
on our foreign operations of approximately 910 basis points, as well as the
impact of nondeductible goodwill impairment charges associated with our Too
Faced, BECCA and Smashbox reporting units of approximately 740 basis points.
Partially offsetting these increases was an increase in excess tax benefit
credits related to stock-based compensation arrangements of approximately 480
basis points.

NET EARNINGS ATTRIBUTABLE TO THE ESTÉE LAUDER COMPANIES INC.


                                                                                   Year Ended June 30
($ in millions, except per share data)                                           2020                2019
As Reported:
Net earnings attributable to The Estée Lauder Companies Inc.                $      684           $   1,785
$ Change from prior year                                                        (1,101)                677
% Change from prior year                                                           (62)  %              61  %
Diluted net earnings per common share                                       $     1.86           $    4.82
% Change from prior year                                                           (61)  %              63  %

Non-GAAP Financial Measure(1): % Change in diluted net earnings per common share from prior year adjusting for the impact of charges associated with restructuring and other activities, goodwill, other intangible and long-lived asset impairments, other income, net, changes in fair value of contingent consideration, the Transition Tax, the remeasurement of U.S. net deferred tax assets as of the TCJA enactment date and the establishment of a net deferred tax liability related to foreign withholding taxes on certain foreign earnings resulting from the TCJA

              (23)  %              18  %


(1)See "Reconciliations of Non-GAAP Financial Measures" beginning on page 46 for reconciliations between non-GAAP financial measures and the most directly comparable U.S. GAAP measures.


                                       45
--------------------------------------------------------------------------------
  Table of Contents
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
We use certain non-GAAP financial measures, among other financial measures, to
evaluate our operating performance, which represent the manner in which we
conduct and view our business. Management believes that excluding certain items
that are not comparable from period to period, or do not reflect the Company's
underlying ongoing business, provides transparency for such items and helps
investors and others compare and analyze our operating performance from period
to period. In the future, we expect to incur charges or adjustments similar in
nature to those presented below; however, the impact to the Company's results in
a given period may be highly variable and difficult to predict. Our non-GAAP
financial measures may not be comparable to similarly titled measures used by,
or determined in a manner consistent with, other companies. While we consider
the non-GAAP measures useful in analyzing our results, they are not intended to
replace, or act as a substitute for, any presentation included in the
consolidated financial statements prepared in conformity with U.S. GAAP. The
following tables present Net sales, Operating income and Diluted net earnings
per common share adjusted to exclude the impact of charges associated with
restructuring and other activities; goodwill and other intangible asset
impairments; long-lived asset impairments relating to COVID-19; other income,
net; the changes in the fair value of contingent consideration; the Transition
Tax; the remeasurement of U.S. net deferred tax assets as of the TCJA enactment
date; the establishment of a net deferred tax liability related to foreign
withholding taxes on certain foreign earnings resulting from the TCJA; and the
effects of foreign currency translation. The tables provide reconciliations
between these non-GAAP financial measures and the most directly comparable U.S.
GAAP measures.

                                                Year Ended June 30                                                                   % Change in
($ in millions, except per share                                                                                         %             Constant
data)                                         2020               2019            Variance                             Change           Currency
Net sales, as reported                    $   14,294          $ 14,863          $   (569)              (4) %               (3) %
Returns associated with
restructuring and other activities                 -                 3      

(3)


Net sales, as adjusted                    $   14,294          $ 14,866          $   (572)              (4) %               (3) %

Operating income, as reported             $      606          $  2,313          $ (1,707)             (74) %              (73) %
Charges associated with
restructuring and other activities                83               241      

(158)

Goodwill, other intangible and
long-lived asset impairments                   1,426                90      

1,336


Changes in fair value of contingent
consideration                                    (17)              (37)     

20


Operating income, as adjusted             $    2,098          $  2,607          $   (509)             (20) %              (19) %

Diluted net earnings per common
share, as reported                        $     1.86          $   4.82          $  (2.96)             (61) %              (60) %
Charges associated with
restructuring and other activities               .19               .51      

(.32)


Other income, net                              (1.20)             (.15)     

(1.05)

Goodwill, other intangible and
long-lived asset impairments                    3.31               .23      

3.08


Changes in fair value of contingent
consideration                                   (.04)             (.08)     

.04


Transition Tax resulting from the
TCJA                                               -              (.03)     

.03


Remeasurement of U.S. net deferred
tax assets as of the TCJA enactment
date                                               -               .02      

(.02)


Net deferred tax liability related
to foreign withholding taxes on
certain foreign earnings resulting
from the TCJA                                      -               .02      

(.02)


Diluted net earnings per common
share, as adjusted                        $     4.12          $   5.34          $  (1.22)             (23) %              (22) %



As diluted net earnings per common share, as adjusted, is used as a measure of
the Company's performance, we consider the impact of current and deferred income
taxes when calculating the per-share impact of each of the reconciling items.
                                       46
--------------------------------------------------------------------------------
  Table of Contents
The following table reconciles the change in net sales by product category and
geographic region, as reported, to the change in net sales excluding the effects
of foreign currency translation:
                                                             As Reported
                                                                                                           Impact of                                                                %
                                                                                                            foreign              Variance,                  %                  Change, in
                                        Year ended              Year ended                                 currency             in constant            Change, as               constant
($ in millions)                        June 30, 2020           June 30, 2019           Variance           translation            currency               reported                currency
By Product Category:
Skin Care                            $        7,382          $        6,551          $     831          $         77          $        908                      13  %                   14  %
Makeup                                        4,794                   5,860             (1,066)                   57                (1,009)                    (18)                    (17)
Fragrance                                     1,563                   1,802               (239)                   18                  (221)                    (13)                    (12)
Hair Care                                       515                     584                (69)                    2                   (67)                    (12)                    (11)
Other                                            40                      69                (29)                    -                   (29)                    (42)                    (42)
                                             14,294                  14,866               (572)                  154                  (418)                     (4)                     (3)
Returns associated with
restructuring and other
activities                                        -                      (3)                 3                     -                     3
Total                                $       14,294          $       14,863          $    (569)         $        154          $       (415)                     (4) %                   (3) %

By Region:
The Americas                         $        3,794          $        4,741          $    (947)         $         (2)         $       (949)                    (20) %                  (20) %
Europe, the Middle East &
Africa                                        6,262                   6,452               (190)                   67                  (123)                     (3)                     (2)
Asia/Pacific                                  4,238                   3,673                565                    89                   654                      15                      18
                                             14,294                  14,866               (572)                  154                  (418)                     (4)                     (3)
Returns associated with
restructuring and other
activities                                        -                      (3)                 3                     -                     3
Total                                $       14,294          $       14,863          $    (569)         $        154          $       (415)                     (4) %                   (3) %


                                       47

--------------------------------------------------------------------------------
  Table of Contents
The following table reconciles the change in operating income by product
category and geographic region, as reported, to the change in operating income
excluding the impact of goodwill, other intangible and long-lived asset
impairments and changes in fair value of contingent consideration:


                                                        As Reported                                                                         Add:
                                                                                                                                         Changes in
                                                                                                                                       Goodwill, other
                                                                                                                                       intangible and                Add:
                                                                                                                                         long-lived            Changes in fair
                                   Year ended              Year ended                                                                       asset            value of contingent          Variance, as
($ in millions)                   June 30, 2020           June 30, 2019          Variance                                                impairments            consideration               adjusted         % Change, as reported      % Change, as adjusted
By Product Category:
Skin Care                       $        2,125          $        1,925          $    200          $      88          $     18          $        306                         10  %                  16  %
Makeup                                  (1,438)                    438     

      (1,876)             1,201                 -                  (675)   

                   (100+)                 (100+)
Fragrance                                   17                     140              (123)                32                 2                   (89)                       (88)                   (70)
Hair Care                                  (19)                     39               (58)                14                 -                   (44)                       (100+)                 (100+)
Other                                        4                      12                (8)                 1                 -                    (7)                       (67)                   (58)
                                           689                   2,554     
$ (1,865)         $   1,336          $     20          $       (509)                       (73) %                 (20) %
Charges associated with
restructuring and other
activities                                 (83)                   (241)
Total                           $          606          $        2,313

By Region:
The Americas                    $       (1,044)         $          672          $ (1,716)         $   1,224          $     20          $       (472)                      (100+)%                 (64) %
Europe, the Middle East &
Africa                                     997                   1,153              (156)               104                 -                   (52)                       (14)                    (5)
Asia/Pacific                               736                     729                 7                  8                 -                    15                          1                      2
                                           689                   2,554          $ (1,865)         $   1,336          $     20          $       (509)                       (73) %                 (20) %
Charges associated with
restructuring and other
activities                                 (83)                   (241)
Total                           $          606          $        2,313



FINANCIAL CONDITION

LIQUIDITY AND CAPITAL RESOURCES
Overview
Our principal sources of funds historically have been cash flows from
operations, borrowings pursuant to our commercial paper program, borrowings from
the issuance of long-term debt and committed and uncommitted credit lines
provided by banks and other lenders in the United States and abroad. At June 30,
2020, we had cash and cash equivalents of $5,022 million compared with $2,987
million at June 30, 2019. In response to the initial global uncertainty
attributable to the COVID-19 pandemic, we issued $700 million of Senior Notes in
April 2020 and borrowed the full amount under our $1,500 million revolving
credit facility in March and April 2020. By the end of June 2020, we had repaid
$750 million under the revolving credit facility, and subsequently repaid the
remaining $750 million in August 2020. Overall these actions were designed to
further enhance our financial flexibility and liquidity. Our cash and cash
equivalents are maintained at a number of financial institutions. To mitigate
the risk of uninsured balances, we select financial institutions based on their
credit ratings and financial strength, and we perform ongoing evaluations of
these institutions to limit our concentration risk exposure.
Based on past performance and current expectations, we believe that cash on
hand, cash generated from operations, available credit lines and access to
credit markets will be adequate to support seasonal working capital needs,
currently planned business operations, information technology enhancements,
capital expenditures, acquisitions, dividends, stock repurchases, restructuring
initiatives, commitments and other contractual obligations on both a near-term
and long-term basis. See Overview - COVID-19 Business Update for actions taken
by us, in response to the impact of COVID-19 on our business, which helped to
mitigate the then expected loss of sales and uncertainties regarding account
receivables and to conserve cash.

                                       48
--------------------------------------------------------------------------------
  Table of Contents
The TCJA, which was enacted during our fiscal 2018, resulted in the Transition
Tax on unrepatriated earnings of our foreign subsidiaries and changed the tax
law in ways that present opportunities to repatriate cash without additional
U.S. federal income tax. As a result, we changed our indefinite reinvestment
assertion related to certain foreign earnings, and we continue to analyze the
indefinite reinvestment assertion on our remaining applicable foreign
earnings. The issuance of guidance subsequent to the enactment of the TCJA has
enabled us to access a substantial portion of the cash in offshore jurisdictions
associated with our permanently reinvested earnings without significant cost. We
do not believe that continuing to reinvest our foreign earnings impairs our
ability to meet our domestic debt or working capital obligations. If these
reinvested earnings were repatriated into the United States as dividends, we
would be subject to state income taxes and applicable foreign taxes in certain
jurisdictions.

The effects of inflation have not been significant to our overall operating
results in recent years. Generally, we have been able to introduce new products
at higher prices, increase prices and implement other operating efficiencies to
sufficiently offset cost increases, which have been moderate.
Credit Ratings
Changes in our credit ratings will likely result in changes in our borrowing
costs. Our credit ratings also impact the cost of our revolving credit
facility. Downgrades in our credit ratings may reduce our ability to issue
commercial paper and/or long-term debt and would likely increase the relative
costs of borrowing. A credit rating is not a recommendation to buy, sell, or
hold securities, is subject to revision or withdrawal at any time by the
assigning rating organization, and should be evaluated independently of any
other rating. As of August 20, 2020, our long-term debt is rated A+ with a
negative outlook by Standard & Poor's and A1 with a stable outlook by Moody's.
Debt and Access to Liquidity
Total debt as a percent of total capitalization (excluding noncontrolling
interests) increased to 61% at June 30, 2020 from 44% at June 30, 2019,
primarily due to the November 2019 issuance of the 2.000% Senior Notes due
December 1, 2024 ("2024 Senior Notes"), 2.375% Senior Notes due December 1, 2029
("2029 Senior Notes") and 3.125% Senior Notes due December 1, 2049 ("2049 Senior
Notes"); the April 2020 issuance of the 2.600% Senior Notes due April 15, 2030
("2030 Senior Notes"); and the $750 million outstanding under our $1,500 million
revolving credit facility at June 30, 2020. Also contributing to the increase
was the decrease in total equity reflecting a decrease in net earnings,
partially offset by lower treasury stock purchases.
For further information regarding our current and long-term debt and available
financing, see Item 8. Financial Statements and Supplementary Data - Note 11 -
Debt.
Cash Flows
                                                                Year Ended June 30
(In millions)                                                   2020           2019
Net cash provided by operating activities                   $    2,280      $  2,517
Net cash provided by (used for) investing activities        $   (1,698)     $    473
Net cash provided by (used for) financing activities        $    1,461      $ (2,173)

The change in net cash flows from operations primarily reflected lower net sales, partially offset by the cost actions taken in response to COVID-19. The lower net sales also reduced working capital needs.



The change in net cash flows from investing activities primarily reflected cash
paid, net of cash acquired, in connection with the fiscal 2020 second quarter
acquisition of Have & Be, as well as lower proceeds from the sale of investments
due to the prior-year liquidation of our foreign subsidiary that owned our
available-for-sale securities.

The change in net cash flows from financing activities primarily reflected
proceeds from the November 2019 and April 2020 issuance of long-term debt,
changes in short-term debt, reflecting current borrowings under our existing
revolving credit facility and the issuance of commercial paper, and lower
treasury stock purchases, partially offset by the repayment of the 2020 Senior
Notes in the current year.
See Item 7. Management's Discussion and Analysis of Financial Condition and
Results of Operations - Financial Condition of the Company's Annual Report on
Form 10-K for the fiscal year ended June 30, 2019 for the fiscal 2019 to fiscal
2018 comparative discussions.
                                       49
--------------------------------------------------------------------------------
  Table of Contents
Dividends
For a summary of quarterly cash dividends declared per share on our Class A and
Class B Common Stock during the year ended June 30, 2020 and through August 20,
2020, see Item 8. Financial Statements and Supplementary Data - Note 17 - Common
Stock. As noted in Item 8. Financial Statements and Supplementary Data - Note 17
- Common Stock, we did not declare quarterly cash dividends that would have been
paid in June 2020.
Pension and Post-retirement Plan Funding
Several factors influence the annual funding requirements for our pension
plans. For our domestic trust-based noncontributory qualified defined benefit
pension plan ("U.S. Qualified Plan"), we seek to maintain appropriate funded
percentages. For any future contributions to the U.S. Qualified Plan, we would
seek to contribute an amount or amounts that would not be less than the minimum
required by the Employee Retirement Income Security Act of 1974, as amended,
("ERISA") and subsequent pension legislation, and would not be more than the
maximum amount deductible for income tax purposes. For each international plan,
our funding policies are determined by local laws and regulations. In addition,
amounts necessary to fund future obligations under these plans could vary
depending on estimated assumptions. The effect of our pension plan funding on
future operating results will depend on economic conditions, employee
demographics, mortality rates, the number of participants electing to take
lump-sum distributions, investment performance and funding decisions.
For the U.S. Qualified Plan, we maintain an investment strategy of matching the
duration of a substantial portion of the plan assets with the duration of the
underlying plan liabilities. This strategy assists us in maintaining our overall
funded ratio. For fiscal 2020 and 2019, we met or exceeded all contribution
requirements under ERISA regulations for the U.S. Qualified Plan. As we continue
to monitor the funded status, we may decide to make cash contributions to the
U.S. Qualified Plan or our post-retirement medical plan in the United States
during fiscal 2021.
The following table summarizes actual and expected benefit payments and
contributions for our other pension and post-retirement plans:
                                                                                     Year Ended June 30
(In millions)                                                       Expected 2021              2020               2019

Non-qualified domestic noncontributory pension plan benefit payments

$       23               $      18          $      19

International defined benefit pension plan contributions $ 25

$      25          $      33
Post-retirement plan benefit payments                             $        8               $       8          $       7



Commitments and Contingencies
Certain of our business acquisition agreements include contingent consideration
or "earn-out" provisions. These provisions generally require that we pay to the
seller or sellers of the business additional amounts based on the performance of
the acquired business. Since the size of each payment depends upon performance
of the acquired business, we do not expect that such payments will have a
material adverse impact on our future results of operations or financial
condition.

For additional contingencies refer to Item 8. Financial Statements and
Supplementary Data - Note 16 - Commitments and Contingencies (Contractual
Obligations).
Contractual Obligations
For a discussion of our contractual obligations, see Item 8. Financial
Statements and Supplementary Data - Note 16 - Commitments and Contingencies
(Contractual Obligations).
Derivative Financial Instruments and Hedging Activities
For a discussion of our derivative financial instruments and hedging activities,
see Item 8. Financial Statements and Supplementary Data - Note 12 - Derivative
Financial Instruments.
Foreign Exchange Risk Management
For a discussion of foreign exchange risk management, see Item 8. Financial
Statements and Supplementary Data - Note 12 - Derivative Financial Instruments
(Cash Flow Hedges, Net Investment Hedges).
Credit Risk
For a discussion of credit risk, see Item 8. Financial Statements and
Supplementary Data - Note 12 - Derivative Financial Instruments (Credit Risk).
                                       50
--------------------------------------------------------------------------------
  Table of Contents
Market Risk
We address certain financial exposures through a controlled program of market
risk management that includes the use of foreign currency forward contracts to
reduce the effects of fluctuating foreign currency exchange rates and to
mitigate the change in fair value of specific assets and liabilities on the
balance sheet. To perform a sensitivity analysis of our foreign currency forward
contracts, we assess the change in fair values from the impact of hypothetical
changes in foreign currency exchange rates. A hypothetical 10% weakening of the
U.S. dollar against the foreign exchange rates for the currencies in our
portfolio would have resulted in a net increase (decrease) in the fair value of
our portfolio of approximately $(222) million and $48 million as of June 30,
2020 and 2019, respectively. This potential change does not consider our
underlying foreign currency exposures.
In addition, we enter into interest rate derivatives to manage the effects of
interest rate movements on our aggregate liability portfolio, including future
debt issuances. Based on a hypothetical 100 basis point increase in interest
rates, the estimated fair value of our interest rate derivatives would increase
(decrease) by approximately $9 million and $(16) million as of June 30, 2020 and
2019, respectively. Our sensitivity analysis represents an estimate of
reasonably possible net losses that would be recognized on our portfolio of
derivative financial instruments assuming hypothetical movements in future
market rates and is not necessarily indicative of actual results, which may or
may not occur. It does not represent the maximum possible loss or any expected
loss that may occur, since actual future gains and losses will differ from those
estimated, based upon actual fluctuations in market rates, operating exposures,
and the timing thereof, and changes in our portfolio of derivative financial
instruments during the year. We believe, however, that any such loss incurred
would be offset by the effects of market rate movements on the respective
underlying transactions for which the derivative financial instrument was
intended.
OFF-BALANCE SHEET ARRANGEMENTS
We do not maintain any off-balance sheet arrangements, transactions, obligations
or other relationships with unconsolidated entities that would be expected to
have a material current or future effect upon our financial condition or results
of operations.
RECENTLY ISSUED ACCOUNTING STANDARDS
Refer to Item 8. Financial Statements and Supplementary Data - Note 2 - Summary
of Significant Accounting Policies for discussion regarding the impact of
accounting standards that were recently issued but not yet effective, on our
consolidated financial statements.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The discussion and analysis of our financial condition at June 30, 2020 and our
results of operations for the three fiscal years ended June 30, 2020 are based
upon our consolidated financial statements, which have been prepared in
conformity with U.S. generally accepted accounting principles ("U.S. GAAP"). The
preparation of these financial statements requires us to make estimates and
assumptions that affect the amounts of assets, liabilities, revenues and
expenses reported in those financial statements. These estimates and assumptions
can be subjective and complex and, consequently, actual results could differ
from those estimates. We consider accounting estimates to be critical if both
(i) the nature of the estimate or assumption is material due to the levels of
subjectivity and judgment involved, and (ii) the impact within a reasonable
range of outcomes of the estimate and assumption is material to the Company's
financial condition. Our critical accounting policies relate to goodwill, other
intangible assets and long-lived assets, income taxes and business combinations.
Management of the Company has discussed the selection of critical accounting
policies and the effect of estimates with the Audit Committee of the Company's
Board of Directors.
Goodwill, Other Intangible Assets and Long-Lived Assets - Impairment Assessment
Goodwill is calculated as the excess of the cost of purchased businesses over
the fair value of their underlying net assets. Other indefinite-lived intangible
assets principally consist of trademarks. Goodwill and other indefinite-lived
intangible assets are not amortized.
When testing goodwill and other indefinite-lived intangible assets for
impairment, we have the option of first performing a qualitative assessment to
determine whether it is more-likely-than-not that the fair value of a reporting
unit is less than its carrying amount as a basis for determining whether it is
necessary to perform a quantitative impairment test. If necessary, we can
perform a single step quantitative goodwill impairment test by comparing the
fair value of a reporting unit with its carrying amount and record an impairment
charge for the amount that the carrying amount exceeds the fair value, up to the
total amount of goodwill allocated to that reporting unit. For fiscal 2020 and
2019, we elected to perform the qualitative assessment for certain of our
reporting units and indefinite-lived intangible assets. This qualitative
assessment included the review of certain macroeconomic factors and
entity-specific qualitative factors to determine if it was more-likely-than-not
that the fair values of our reporting units were below carrying value. For our
other reporting units and other indefinite-lived intangible assets, a
quantitative assessment was performed. We engaged third-party valuation
specialists and used industry accepted valuation models and criteria that were
reviewed and approved by various levels of management.
                                       51
--------------------------------------------------------------------------------
  Table of Contents
For further discussion of the methods used and factors considered in our
estimates as part of the impairment testing for Goodwill, Other Intangible
Assets and Long-Lived Assets, see Item 8. Financial Statements and Supplementary
Data - Note 2 - Summary of Significant Accounting Policies, Note 6 - Goodwill
and Other Intangible Assets and Note 7 - Leases.

Income Taxes
We calculate and provide for income taxes in each tax jurisdiction in which we
operate. As the application of various tax laws relevant to our global business
is often uncertain, significant judgment is required in determining our annual
tax expense and in evaluating our tax positions. The provision for income taxes
includes the amounts payable or refundable for the current year, the effect of
deferred taxes and impacts from uncertain tax positions.
We recognize deferred tax assets and liabilities for future tax consequences
attributable to differences between financial statement carrying amounts of
existing assets and liabilities and their respective tax basis, net operating
losses, tax credit and other carryforwards. Deferred tax assets and liabilities
are measured using enacted tax rates when the assets and liabilities are
expected to be realized or settled. We regularly review deferred tax assets for
realizability and establish valuation allowances based on available evidence
including historical operating losses, projected future taxable income, expected
timing of the reversals of existing temporary differences, and appropriate tax
planning strategies. If our assessment of the realizability of a deferred tax
asset changes, an increase to a valuation allowance will result in a reduction
of net earnings at that time, while the reduction of a valuation allowance will
result in an increase of net earnings at that time.
We provide tax reserves for U.S. federal, state, local and foreign tax exposures
relating to periods subject to audit. The development of reserves for these
exposures requires judgments about tax issues, potential outcomes and timing,
and is a subjective critical estimate. We assess our tax positions and record
tax benefits for all years subject to examination based upon management's
evaluation of the facts, circumstances, and information available at the
reporting dates. For those tax positions where it is more-likely-than-not that a
tax benefit will be sustained, we have recorded the largest amount of tax
benefit with a greater than 50% likelihood of being realized upon settlement
with a tax authority that has full knowledge of all relevant information. For
those tax positions where it is more-likely-than-not that a tax benefit will not
be sustained, no tax benefit has been recognized in the consolidated financial
statements. We classify applicable interest and penalties as a component of the
provision for income taxes. Although the outcome relating to these exposures is
uncertain, in our opinion adequate provisions for income taxes have been made
for estimable potential liabilities emanating from these exposures. If actual
outcomes differ materially from these estimates, they could have a material
impact on our consolidated net earnings.
For further discussion of our Income Taxes accounting policy, see Item 8.
Financial Statements and Supplementary Data - Note 2 - Summary of Significant
Accounting Policies.
Business Combinations
We use the acquisition method of accounting for acquired businesses. Under the
acquisition method, our consolidated financial statements reflect the operations
of an acquired business starting from the closing date of the acquisition. We
allocate the purchase price to the tangible and identifiable intangible assets
acquired and liabilities assumed based on their estimated fair values on the
acquisition date. Any residual purchase price is recorded as goodwill. The
determination of fair value, as well as the expected useful lives of certain
assets acquired, requires management to make judgements and may involve the use
of significant estimates, including assumptions with respect to estimated future
cash flows, discount rates and valuation multiples from comparable publicly
traded companies, among other things. Management estimates of fair value are
based upon assumptions believed to be reasonable, but which are inherently
uncertain and unpredictable.

During fiscal 2020, we acquired the remaining 66.66% equity interest in Have &
Be. We originally acquired a minority interest in Have & Be in December 2015,
and that investment structure included a formula-based call option for the
remaining equity interest. The original minority interest was accounted for as
an equity method investment. The acquisition of the remaining equity interest in
Have & Be was considered a step acquisition, whereby we remeasured the
previously held equity method investment to its fair value, resulting in the
recognition of a gain. The acquisition of the remaining equity interest also
resulted in the recognition of a previously unrealized foreign currency gain,
which was reclassified from accumulated other comprehensive income. The fair
value of the previously held equity method investment was determined based upon
a valuation of the acquired business, as of the date of acquisition, using an
equal weighting of the income and market approaches, utilizing estimated cash
flows and a terminal value, discounted at a rate of return that reflects the
relative risk of the cash flows, as well as valuation multiples derived from
comparable publicly traded companies.

We allocated the total consideration transferred, which included the cash paid
at closing and the fair value of our previously held equity method investment,
to the tangible and identifiable intangible assets acquired and liabilities
assumed based on their fair value at the acquisition date. The excess of the
total consideration transferred over the fair value of the net tangible and
intangible assets acquired was recorded as goodwill.
                                       52
--------------------------------------------------------------------------------
  Table of Contents
For further discussion of our Business Combinations accounting policy, see Item
8. Financial Statements and Supplementary Data - Note 2 - Summary of Significant
Accounting Policies.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION
We and our representatives from time to time make written or oral
forward-looking statements, including in this and other filings with the
Securities and Exchange Commission, in our press releases and in our reports to
stockholders, which may constitute "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995. Such statements
may address our expectations regarding sales, earnings or other future financial
performance and liquidity, other performance measures, product introductions,
entry into new geographic regions, information technology initiatives, new
methods of sale, our long-term strategy, restructuring and other charges and
resulting cost savings, and future operations or operating results. These
statements may contain words like "expect," "will," "will likely result,"
"would," "believe," "estimate," "planned," "plans," "intends," "may," "should,"
"could," "anticipate," "estimate," "project," "projected," "forecast," and
"forecasted" or similar expressions. Although we believe that our expectations
are based on reasonable assumptions within the bounds of our knowledge of our
business and operations, actual results may differ materially from our
expectations. Factors that could cause actual results to differ from
expectations include, without limitation:
(1)increased competitive activity from companies in the skin care, makeup,
fragrance and hair care businesses;
(2)our ability to develop, produce and market new products on which future
operating results may depend and to successfully address challenges in our
business;
(3)consolidations, restructurings, bankruptcies and reorganizations in the
retail industry causing a decrease in the number of stores that sell our
products, an increase in the ownership concentration within the retail industry,
ownership of retailers by our competitors or ownership of competitors by our
customers that are retailers and our inability to collect receivables;
(4)destocking and tighter working capital management by retailers;
(5)the success, or changes in timing or scope, of new product launches and the
success, or changes in timing or scope, of advertising, sampling and
merchandising programs;
(6)shifts in the preferences of consumers as to where and how they shop;
(7)social, political and economic risks to our foreign or domestic
manufacturing, distribution and retail operations, including changes in foreign
investment and trade policies and regulations of the host countries and of the
United States;
(8)changes in the laws, regulations and policies (including the interpretations
and enforcement thereof) that affect, or will affect, our business, including
those relating to our products or distribution networks, changes in accounting
standards, tax laws and regulations, environmental or climate change laws,
regulations or accords, trade rules and customs regulations, and the outcome and
expense of legal or regulatory proceedings, and any action we may take as a
result;
(9)foreign currency fluctuations affecting our results of operations and the
value of our foreign assets, the relative prices at which we and our foreign
competitors sell products in the same markets and our operating and
manufacturing costs outside of the United States;
(10)changes in global or local conditions, including those due to the volatility
in the global credit and equity markets, natural or man-made disasters, real or
perceived epidemics, or energy costs, that could affect consumer purchasing, the
willingness or ability of consumers to travel and/or purchase our products while
traveling, the financial strength of our customers, suppliers or other contract
counterparties, our operations, the cost and availability of capital which we
may need for new equipment, facilities or acquisitions, the returns that we are
able to generate on our pension assets and the resulting impact on funding
obligations, the cost and availability of raw materials and the assumptions
underlying our critical accounting estimates;
(11)impacts attributable to the COVID-19 pandemic, including disruptions to our
global business;
(12)shipment delays, commodity pricing, depletion of inventory and increased
production costs resulting from disruptions of operations at any of the
facilities that manufacture our products or at our distribution or inventory
centers, including disruptions that may be caused by the implementation of
information technology initiatives, or by restructurings;
                                       53
--------------------------------------------------------------------------------
  Table of Contents
(13)real estate rates and availability, which may affect our ability to increase
or maintain the number of retail locations at which we sell our products and the
costs associated with our other facilities;
(14)changes in product mix to products which are less profitable;
(15)our ability to acquire, develop or implement new information and
distribution technologies and initiatives on a timely basis and within our cost
estimates and our ability to maintain continuous operations of such systems and
the security of data and other information that may be stored in such systems or
other systems or media;
(16)our ability to capitalize on opportunities for improved efficiency, such as
publicly-announced strategies and restructuring and cost-savings initiatives,
and to integrate acquired businesses and realize value therefrom;
(17)consequences attributable to local or international conflicts around the
world, as well as from any terrorist action, retaliation and the threat of
further action or retaliation;
(18)the timing and impact of acquisitions, investments and divestitures; and
(19)additional factors as described in our filings with the Securities and
Exchange Commission, including this Annual Report on Form 10-K for the fiscal
year ended June 30, 2020.
We assume no responsibility to update forward-looking statements made herein or
otherwise.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk. The information required by this item is set forth in Item 7 of this Annual Report on Form 10-K under the caption Liquidity and Capital Resources - Market Risk and is incorporated herein by reference.

© Edgar Online, source Glimpses